Skip to Main Content

Author Details

Chaitanya Divgi
Columbia University Medical Center Kreitchman PET Center
1981
157
46
PMIDPaper TitleJournal TitlePublished Year
37657154Evaluation of a semi-automated approach for FDG PET image analysis for routine clinical application in patients with multiple myeloma.Transl Oncol2023
33309909Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy.Int J Radiat Oncol Biol Phys2021
32374053Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.Oncologist2020
31961822Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.J Clin Invest2020
31773210Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [<sup>11</sup>C]-(+)-PHNO.Psychopharmacology (Berl)2020
33438607A threshold-based method to predict thyroid nodules on scintigraphy scans.Biomed Phys Eng Express2020
32800518Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma.Clin Lymphoma Myeloma Leuk2020
30528751Imaging Characterization of Thyroid Nodules.Acad Radiol2019
30077557A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).J Urol2019
31565950ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals.Ann ICRP2019
31002399Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method.Transfusion2019
29119236Imaging the multiple facets of immuno-oncology.Eur J Nucl Med Mol Imaging2018
29959211The Current State of Radiopharmaceutical Therapy.J Nucl Med2018
27941245Prolonged red cell storage before transfusion increases extravascular hemolysis.J Clin Invest2017
26719162Do We Need Yet Another Hybrid Imaging Device?Acad Radiol2016
26370678Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.Mol Imaging Biol2016
27485414An analysis of the relationship between metastases and cachexia in lung cancer patients.Cancer Med2016
25984435Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors.EJNMMI Res2015
26202566Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of Lymphedema.Ann Surg Oncol2015
26194713PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.Eur J Nucl Med Mol Imaging2015
24108668Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.Cancer2014
25294899Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.Clin Cancer Res2014
24775723Imaging approaches with advanced prostate cancer: techniques and timing.Can J Urol2014
24553243Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.Cancer Biol Ther2014
24525208Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin.J Nucl Med2014
24309382Whither goest thou, radiopharmaceutical therapy?J Nucl Med2014
22267446Fluorodeoxyglucose-induced allergic reaction: a case report.J Oncol Pharm Pract2013
23731770Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer.EJNMMI Res2013
23453080A review of contemporary data on surgically resected renal masses--benign or malignant?Urology2013
23213092Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.J Clin Oncol2013
22414633Bone marrow dosimetry using 124I-PET.J Nucl Med2012
23145366American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2012) e-Century Publishing Corporation.Am J Nucl Med Mol Imaging2012
22787108The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0.J Nucl Med2012
22897720Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.Cancer Biother Radiopharm2012
21421715Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250.J Nucl Med2011
23133798American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2011) e-Century Publishing Corporation.Am J Nucl Med Mol Imaging2011
23133791Launch of the american journal of nuclear medicine and molecular imaging.Am J Nucl Med Mol Imaging2011
22068895124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.J Nucl Med2011
22144871Dosimetric considerations in radioimmunotherapy and systemic radionuclide therapies: a review.World J Nucl Med2011
21803187Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer.Semin Nucl Med2011
21803186Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.Semin Nucl Med2011
21764796(124)I-huA33 antibody PET of colorectal cancer.J Nucl Med2011
21576462Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.Proc Natl Acad Sci U S A2011
21711220Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography.Med Chem2011
20133256Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results.Clin Breast Cancer2010
20858843Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.Clin Cancer Res2010
20585774Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.Eur J Nucl Med Mol Imaging2010
19242386Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent.Nucl Med Commun2009
22470675CT and 111In-pentetreotide SPECT of hilar ACTH-producing neuroendocrine tumor associated with Cushing's syndrome and massive bilateral adrenal gland hyperplasia.J Radiol Case Rep2009
19687220Molecular imaging of pulmonary cancer and inflammation.Proc Am Thorac Soc2009
  • 1 - 50 of 157

Recommended Authors

university of california los angeles
Career Start Year 2014
Number of shared co-authors 5
UT MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
University of California san francisco
Career Start Year 2007
Number of shared co-authors 2
University of California san francisco
Career Start Year 2007
Number of shared co-authors 8
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Maastricht University
Career Start Year 2003
Number of shared co-authors 0
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2000
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 1
University of Fukui.
Career Start Year 1997
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Career Start Year 1993
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year 1990
Number of shared co-authors 1
Center for Cancer Research
Career Start Year 1990
Number of shared co-authors 1
First Hospital of Shanxi Medical University, Shanxi Medical University
Career Start Year 1989
Number of shared co-authors 1
David Geffen School of Medicine, university of california los angeles
Career Start Year 1988
Number of shared co-authors 2
university of california los angeles
Career Start Year 1987
Number of shared co-authors 4
University of Iowa
Career Start Year 1986
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 1
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 5
City of Hope National Medical Center
Career Start Year 1982
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 6
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 0
Wake Forest University School of Medicine
Career Start Year 1972
Number of shared co-authors 0
Keck School of Medicine of USC
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Ludwig Institute for Cancer Research
Co-authored papers 21
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Memorial Sloan Kettering Cancer Center
Co-authored papers 14
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Co-authored papers 4
Department of Radiology Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Columbia University Irving Medical Center
Co-authored papers 3
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 3
Columbia University Irving Medical Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 3
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 3
Marcus Center for Cellular Cures, Duke University
Co-authored papers 3
Gui de Chauliac Hospital, Montpellier University Medical Center
Co-authored papers 3
Spanish National Cancer Research Centre-CNIO
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
NewYork-Presbyterian/Columbia University Irving Medical Center
Co-authored papers 2
Istituto di Ricerche Farmacologiche Mario Negri
Co-authored papers 2
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 2
University of Virginia
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 1
Sandra and Edward Meyer Cancer Center
Co-authored papers 1
Northwestern University
Co-authored papers 1
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1